126 results
Page 4 of 7
8-K
06m 9615n3m75m
1 Jul 22
Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven
8:45am
8-K
huh9 x3f0
30 Jun 22
Submission of Matters to a Vote of Security Holders
4:34pm
DEFA14A
dd56fj596lmmo
9 Jun 22
Additional proxy soliciting materials
9:06am
8-K
EX-99.2
gfytc28im8hub
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
DEF 14A
92pik
23 May 22
Definitive proxy
8:00am
10-K/A
kzuxoqnbz
2 May 22
Annual report (amended)
4:30pm
8-K
EX-99.2
jrw1afyhrgw922f
30 Mar 22
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
4:06pm
10-K
s4ydgyqt86
30 Mar 22
Annual report
12:00am
10-K
EX-10.35
89yjrd
30 Mar 22
Annual report
12:00am
10-K
EX-23.1
nhtix
30 Mar 22
Annual report
12:00am
8-K/A
EX-99.1
ejs egz5foy
14 Mar 22
Unregistered Sales of Equity Securities
7:38am
8-K
EX-99.1
d9cs jogby
24 Feb 22
Unregistered Sales of Equity Securities
7:37am
8-K
EX-99.1
37foci78r
14 Dec 21
Regulation FD Disclosure
7:58am
8-K
EX-99.2
9rdeztdfbfo74
1 Nov 21
Regulation FD Disclosure
7:38am
8-K
EX-99.2
vouos07j b72ekhm1xqa
9 Sep 21
Regulation FD Disclosure
7:34am
10-Q
yhhaj77evxmqpnb1eor
16 Aug 21
Quarterly report
7:07am
S-8
EX-23.3
hhn57rymh08jx
11 Jun 21
Registration of securities for employees
4:16pm